DrugScience and Dartmouth Films are happy to announce that there will be an online screening of the documentary MAGIC MEDICINE on Tuesday 05 May followed by a live Q&A with Professor David Nutt and Dr Rosalind Watts.

MAGIC MEDICINE (79 mins)

Can magic mushrooms cure depression?

Over 4 years, filmmaker Monty Wates was given exclusive access to the first ever medical trial to give psilocybin (the psychoactive ingredient in magic mushrooms) to a group of volunteers suffering from clinical depression. His remarkable film follows three of the volunteers and their families, and the ambitious staff running the trial, who are hoping this controversial treatment will have the power to transform millions of lives.

With deeply moving footage of the 'trips' the patients go on, this intimate film is an absorbing portrait of the human cost of depression, and the inspirational people contributing to groundbreaking psychedelic research.

Ticket holders will be emailed a screening and Q&A link on the day of the event.

Timings below:

6:00pm (BST): Ticket holders receive links to the screening + live Q&A

7:00pm (BST): Recommended film start time

8:30pm (BST): Live Q&A start time

If you have any questions, please contact screenings@dartmouthfilms.com.

Speaker Profiles:

Prof David Nutt is currently the Edmond J. Safra Professor of Neuropsychopharmacology at Imperial College London. He is also the Chair of DrugScience (formally the Independent Scientific Committee on Drugs (ISCD) and President of the European Brain Council. David has previously worked as an advisor to the Ministry of Defence, Department of Health and the Home Office. He broadcasts widely to the general public both on radio and television including BBC science and public affairs programmes on therapeutic as well as illicit drugs, their harms and their classification.

Dr Rosalind Watts is the Clinical Lead of the Imperial College Psilocybin for Depression trial (Psilodep 2). She trained as a clinical psychologist at UCL and practised psychotherapy for 6 years before joining the Imperial Psychedelic Research Group, led by Robin Carhart-Harris. Rosalind designed the therapy protocol for Psilodep 2, works as a lead 'guide' alongside three other therapists, and is running the day-to-day aspects of the trial.

Buying a ticket to this screening gives DrugScience and Dartmouth Films the permission to contact ticket holders at the email address used, communication which one may unsubscribe from at any time.